Basing on CD3+ and cytotoxic CD8+ T cells in a tumor, another study constructed an immune score system and revealed that the immune score system provides reliable information on the risk of recurrence in patients with colon cancer (27). This evidence concerns the gene CD8A and colonic neoplasm.